TY - JOUR
T1 - OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen
AU - Murata, Satoshi
AU - Ladle, Brian H.
AU - Kim, Peter S.
AU - Lutz, Eric R.
AU - Wolpoe, Matthew E.
AU - Ivie, Susan E.
AU - Smith, Holly M.
AU - Armstrong, Todd D.
AU - Emens, Leisha A.
AU - Jaffee, Elizabeth M.
AU - Reilly, R. Todd
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2006/1/15
Y1 - 2006/1/15
N2 - T cell costimulation via OX40 is known increase CD4+ T cell expansion and effector function and enhances the development of T cell memory. OX40 costimulation can also prevent, and even reverse, CD4+ T cell anergy. However, the role of OX40 in CD8+ T cell function is less well defined, particularly in the setting of immune tolerance. To determine the effects of OX40 costimulation on the induction of the host CO8+ T cell repertoire to an endogenous tumor Ag, we examined the fate of CD8 + T cells specific for the immunodominant rat HER-2/neu epitope, RNEU420-429, in FVB MMTV-neu (neu-N) mice, which express rat HER-2/neu protein in a predominantly mammary-restricted fashion. We show that the RNEU420-429-specific T cell repertoire in neu-N mice expands transiently after vaccination with a neu-targeted GM-CSF-secreting whole-cell vaccine, but quickly declines to an undetectable level. However, OX40 costimulation, when combined with GM-CSF-secreting tumor-targeted vaccination, can break established CD8+ T cell tolerance in vivo by enhancing the expansion, and prolonging the survival and effector function of CO8+ T cells specific for RNEU420-429. Moreover, we demonstrate thai OX40 expression is up-regulated on both CD4+ and CD8+ T cells shortly after administration of a GM-CSF expressing vaccine. These studies highlight the increased efficacy of OX40 costimulation when combined with a GM-CSF-secreting vaccine, and define a new role for OX40 costimulation of CD8+ T cells in overcoming tolerance and boosting antitumor immunity.
AB - T cell costimulation via OX40 is known increase CD4+ T cell expansion and effector function and enhances the development of T cell memory. OX40 costimulation can also prevent, and even reverse, CD4+ T cell anergy. However, the role of OX40 in CD8+ T cell function is less well defined, particularly in the setting of immune tolerance. To determine the effects of OX40 costimulation on the induction of the host CO8+ T cell repertoire to an endogenous tumor Ag, we examined the fate of CD8 + T cells specific for the immunodominant rat HER-2/neu epitope, RNEU420-429, in FVB MMTV-neu (neu-N) mice, which express rat HER-2/neu protein in a predominantly mammary-restricted fashion. We show that the RNEU420-429-specific T cell repertoire in neu-N mice expands transiently after vaccination with a neu-targeted GM-CSF-secreting whole-cell vaccine, but quickly declines to an undetectable level. However, OX40 costimulation, when combined with GM-CSF-secreting tumor-targeted vaccination, can break established CD8+ T cell tolerance in vivo by enhancing the expansion, and prolonging the survival and effector function of CO8+ T cells specific for RNEU420-429. Moreover, we demonstrate thai OX40 expression is up-regulated on both CD4+ and CD8+ T cells shortly after administration of a GM-CSF expressing vaccine. These studies highlight the increased efficacy of OX40 costimulation when combined with a GM-CSF-secreting vaccine, and define a new role for OX40 costimulation of CD8+ T cells in overcoming tolerance and boosting antitumor immunity.
UR - http://www.scopus.com/inward/record.url?scp=30744445700&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=30744445700&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.176.2.974
DO - 10.4049/jimmunol.176.2.974
M3 - Article
C2 - 16393983
AN - SCOPUS:30744445700
SN - 0022-1767
VL - 176
SP - 974
EP - 983
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -